When Should Open-Label Extension Studies Be Stopped?

被引:0
作者
Crites, Joshua S. [1 ]
机构
[1] Penn State Coll Med, Hershey, PA 17033 USA
关键词
CLINICAL-TRIALS;
D O I
10.1080/15265161.2014.889957
中图分类号
B82 [伦理学(道德学)];
学科分类号
摘要
引用
收藏
页码:57 / 58
页数:2
相关论文
共 6 条
[1]  
Casarett D, 2001, IRB, V23, P1, DOI 10.2307/3563676
[2]   Open-label extension studies - Do they provide meaningful information on the safety of new drugs? [J].
Day, Richard O. ;
Williams, Kenneth M. .
DRUG SAFETY, 2007, 30 (02) :93-105
[3]   The therapeutic orientation to clinical trials [J].
Miller, FG ;
Rosenstein, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (14) :1383-1386
[4]   A critique of clinical equipoise - Therapeutic misconception in the ethics of clinical trials [J].
Miller, FG ;
Brody, H .
HASTINGS CENTER REPORT, 2003, 33 (03) :19-28
[5]   Open label extension studies: research or marketing? [J].
Taylor, GJ ;
Wainwright, P .
BRITISH MEDICAL JOURNAL, 2005, 331 (7516) :572-574
[6]   Consent to open label extension studies: some ethical issues [J].
Wainwright, P .
JOURNAL OF MEDICAL ETHICS, 2002, 28 (06) :373-376